INHIBITION OF SPARTEINE OXIDATION IN HUMAN-LIVER BY TRICYCLIC ANTI-DEPRESSANTS AND OTHER DRUGS

被引：76

作者：

OTTON, SV

INABA, T

KALOW, W

机构：

来源：

LIFE SCIENCES | 1983年 / 32卷 / 07期

关键词：

D O I：

10.1016/0024-3205(83)90315-6

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：795 / 800

页数：6

共 20 条

[1] PHARMACOGENETIC COVARIATION OF DEFECTIVE N-OXIDATION OF SPARTEINE AND 4-HYDROXYLATION OF DEBRISOQUINE [J].

BERTILSSON, L ;

DENGLER, HJ ;

EICHELBAUM, M ;

SCHULZ, HU .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 17 (02) :153-155

[2]

COCCIA PF, 1967, J PHARMACOL EXP THER, V157, P446

[3] INFLUENCE OF THE GENETICALLY CONTROLLED DEFICIENCY IN DEBRISOQUINE HYDROXYLATION ON ANTIPYRINE METABOLITE FORMATION [J].

DANHOF, M ;

IDLE, JR ;

TEUNISSEN, MWE ;

SLOAN, TP ;

BREIMER, DD ;

SMITH, RL .

PHARMACOLOGY, 1981, 22 (06) :349-358

[4] APPARENT MICHAELIS CONSTANTS FOR METABOLISM OF (UREYL-C-14)TOLBUTAMIDE BY HUMAN LIVER MICROSOMAL PREPARATIONS [J].

DARBY, FJ ;

EVANS, DAP ;

GRUNDY, RK .

BIOCHEMICAL PHARMACOLOGY, 1972, 21 (03) :407-&

[5]

Dixon M., 1964, ENZYMES, P328

[6]

EICHELBAUM M, 1982, CLIN PHARMACOKINET, V7, P1, DOI 10.2165/00003088-198207010-00001

[7]

EICHELBAUM M, 1975, THESIS U BONN

[8]

IDLE JR, 1979, BRIT J PHARMACOL, V66, pP430

[9] DEFICIENT METABOLISM OF DEBRISOQUINE AND SPARTEINE [J].

INABA, T ;

OTTON, SV ;

KALOW, W .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (04) :547-549

[10] SPECTROPHOTOMETRIC AND TURBIDIMETRIC METHODS FOR MEASURING PROTEINS [J].

LAYNE, E .

METHODS IN ENZYMOLOGY, 1957, 3 :447-454

← 1 2 →